Target intelligence / Profile preview

Immunoglobulin heavy diversity 3-10 (IGHD3-10)

Target
IGHD3-10
Molecular classification
Other (Immunoglobulin diversity gene segment)
01

Overview

Immunoglobulin heavy diversity 3-10 (IGHD3-10) is one of the diversity (D) gene segments within the immunoglobulin heavy chain (IGH) locus on human chromosome 14q32.33. The IGHD gene segments, including IGHD3-10, are involved in the somatic recombination process during B-cell development, where one variable (V), one diversity (D), and one joining (J) segment are assembled to encode the variable region of immunoglobulin heavy chains. This combinatorial process underlies the vast diversity of antibodies in the adaptive immune system. IGHD3-10 itself is a short, non-coding DNA segment that becomes part of the third complementarity-determining region (CDR-H3) of the antibody, which is critical for antigen binding. The gene is not a receptor, enzyme, transporter, or direct therapeutic target, but is essential in generating antibody diversity. It is not directly associated with specific diseases, nor targeted by drugs, biomarkers, or recognized for safety issues. Key Points: - IGHD3-10 is a germline gene segment rather than a full-length gene or protein. - Its function is to provide diversity to the antibody repertoire through V(D)J recombination, crucial for humoral immunity. - It is not a therapeutic target nor implicated in diseases directly; thus, there are no known interacting drugs, mechanisms of action, or clinical biomarkers associated specifically with IGHD3-10.

Other names
IGHD310DXP'1
02

Biological functions

Immune response (generation of antibody diversity through V(D)J recombination)
03

Disease associations

Other (Contributes to immune repertoire but not directly implicated as a disease gene)

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 3-10 (IGHD3-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 3-10 (IGHD3-10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call